Pyxis Oncology Inc (PYXS) Stock Price, Quote, News & History

PYXSNASDAQ
$2.67
0.031.14%
At close: Jul 10, 5:00 PM EST
$2.67
N/A
After Hours: Jul 10, 5:38 PM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-66.97M
Investing Cash Flow (TTM)
59.41M
Financing Cash Flow (TTM)
569.00K
Free Cash Flow (TTM)
-66.98M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
-6.99M

Analyst Trends and Forecast

2
Mar
1
May
1
Jul
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$147.67M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
11.95
PB Ratio (TTM)
5.35
Earnings Yield % (TTM)
-49.24%
Earnings Yield % (FWD)
-45.08%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.49

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$5.77M
Debt to Equity
0.58
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$2.64
Close
$2.67
Volume / Avg.
853.13K / 835.24K
Day Range
$2.40 - $2.69
52 Wk Range
0.97 - 5.55
Market Cap
$169.16M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
58
Short Interest
4.89%
Days to Cover
1.25

About

Sector
Health Care
Industry
Biotechnology
Pyxis Oncology Inc is a clinical-stage oncology company focused on developing therapies for patients with solid tumors, with an initial emphasis on head and neck squamous cell carcinoma. Its product candidate, micvotabart pelidotin (MICVO, formerly P...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Pyxis Oncology (PYXS) stock?

A

You can purchase shares of Pyxis Oncology (NASDAQ:PYXS) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Pyxis Oncology (PYXS) competitors?

A

There are no as such competitors for Pyxis Oncology.

Q

What is the forecast, or price target, for Pyxis Oncology (PYXS) stock?

A

Pyxis Oncology has a consensus price target of $8.10.

Q

What is the current price for Pyxis Oncology (PYXS)?

A

The stock price for Pyxis Oncology (NASDAQ: PYXS) is $2.67 last updated July 10, 2026 at 5:38 PM EDT.

Q

Does Pyxis Oncology (PYXS) pay a dividend?

A

There are no upcoming dividends for Pyxis Oncology.

Q

When is Pyxis Oncology (NASDAQ:PYXS) reporting earnings?

A

Pyxis Oncology does not have any upcoming earnings scheduled.

Q

Is Pyxis Oncology (PYXS) going to split?

A

There is no upcoming split for Pyxis Oncology.

Q

What sector and industry does Pyxis Oncology (PYXS) operate in?

A

Pyxis Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.